Follow
George Foussias, MD PhD FRCPC
George Foussias, MD PhD FRCPC
Centre for Addiction and Mental Health, University of Toronto
Verified email at camh.ca
Title
Cited by
Cited by
Year
Negative symptoms in schizophrenia: avolition and Occam's razor
G Foussias, G Remington
Schizophrenia bulletin 36 (2), 359-369, 2010
7402010
Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders
G Foussias, O Agid, G Fervaha, G Remington
European Neuropsychopharmacology 24 (5), 693-709, 2014
2712014
An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis
O Agid, T Arenovich, G Sajeev, RB Zipursky, S Kapur, G Foussias, ...
Journal of Clinical Psychiatry 72 (11), 1439, 2011
2652011
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia
G Fervaha, G Foussias, O Agid, G Remington
Acta Psychiatrica Scandinavica 130 (4), 290-299, 2014
2602014
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
G Fervaha, A Graff-Guerrero, KK Zakzanis, G Foussias, O Agid, ...
Journal of psychiatric research 47 (11), 1590-1596, 2013
2362013
Impact of primary negative symptoms on functional outcomes in schizophrenia
G Fervaha, G Foussias, O Agid, G Remington
European Psychiatry 29 (7), 449-455, 2014
2282014
Treating negative symptoms in schizophrenia: an update
G Remington, G Foussias, G Fervaha, O Agid, H Takeuchi, J Lee, M Hahn
Current treatment options in psychiatry 3, 133-150, 2016
2032016
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome
G Fervaha, G Foussias, O Agid, G Remington
Schizophrenia research 166 (1-3), 9-16, 2015
1832015
Neuroimaging evidence for the deficit subtype of schizophrenia
AN Voineskos, G Foussias, J Lerch, D Felsky, G Remington, TK Rajji, ...
JAMA psychiatry 70 (5), 472-480, 2013
1792013
Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits
G Foussias, S Mann, KK Zakzanis, R Van Reekum, O Agid, G Remington
Schizophrenia research 132 (1), 24-27, 2011
1712011
Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
A Moros, V Rodriguez, I Saborit-Villarroya, A Montraveta, P Balsas, ...
Leukemia 28 (10), 2049, 2014
165*2014
Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia
H Takeuchi, C Siu, G Remington, G Fervaha, RB Zipursky, G Foussias, ...
Neuropsychopharmacology 44 (6), 1036-1042, 2019
1592019
Motivational deficits and cognitive test performance in schizophrenia
G Fervaha, KK Zakzanis, G Foussias, A Graff-Guerrero, O Agid, ...
JAMA psychiatry 71 (9), 1058-1065, 2014
1552014
Anhedonia in depression and schizophrenia: a transdiagnostic challenge
C Lambert, S Da Silva, AK Ceniti, SJ Rizvi, G Foussias, SH Kennedy
CNS neuroscience & therapeutics 24 (7), 615-623, 2018
1352018
Motivational deficits as the central link to functioning in schizophrenia: a pilot study
G Foussias, S Mann, KK Zakzanis, R Van Reekum, G Remington
Schizophrenia Research 115 (2-3), 333-337, 2009
1342009
Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls
S Shahab, BH Mulsant, ML Levesque, N Calarco, A Nazeri, AL Wheeler, ...
Neuropsychopharmacology 44 (5), 898-906, 2019
1302019
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?
G Remington, O Agid, G Foussias, L Ferguson, K McDonald, V Powell
Psychopharmacology 225, 505-518, 2013
1222013
Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis
AL Wheeler, M Wessa, PR Szeszko, G Foussias, MM Chakravarty, ...
JAMA psychiatry 72 (5), 446-455, 2015
1082015
Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification
S Farooq, O Agid, G Foussias, G Remington
Schizophrenia bulletin 39 (6), 1169-1172, 2013
1072013
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
O Agid, G Foussias, G Remington
Expert Opinion on Pharmacotherapy 11 (14), 2301-2317, 2010
1032010
The system can't perform the operation now. Try again later.
Articles 1–20